| Literature DB >> 26426272 |
Kenneth A Field1, Joseph S Johnson1, Thomas M Lilley1, Sophia M Reeder1, Elizabeth J Rogers1, Melissa J Behr2, DeeAnn M Reeder1.
Abstract
White-nose syndrome (WNS) in North American bats is caused by an invasive cutaneous infection by the psychrophilic fungus Pseudogymnoascus destructans (Pd). We compared transcriptome-wide changes in gene expression using RNA-Seq on wing skin tissue from hibernating little brown myotis (Myotis lucifugus) with WNS to bats without Pd exposure. We found that WNS caused significant changes in gene expression in hibernating bats including pathways involved in inflammation, wound healing, and metabolism. Local acute inflammatory responses were initiated by fungal invasion. Gene expression was increased for inflammatory cytokines, including interleukins (IL) IL-1β, IL-6, IL-17C, IL-20, IL-23A, IL-24, and G-CSF and chemokines, such as Ccl2 and Ccl20. This pattern of gene expression changes demonstrates that WNS is accompanied by an innate anti-fungal host response similar to that caused by cutaneous Candida albicans infections. However, despite the apparent production of appropriate chemokines, immune cells such as neutrophils and T cells do not appear to be recruited. We observed upregulation of acute inflammatory genes, including prostaglandin G/H synthase 2 (cyclooxygenase-2), that generate eicosanoids and other nociception mediators. We also observed differences in Pd gene expression that suggest host-pathogen interactions that might determine WNS progression. We identified several classes of potential virulence factors that are expressed in Pd during WNS, including secreted proteases that may mediate tissue invasion. These results demonstrate that hibernation does not prevent a local inflammatory response to Pd infection but that recruitment of leukocytes to the site of infection does not occur. The putative virulence factors may provide novel targets for treatment or prevention of WNS. These observations support a dual role for inflammation during WNS; inflammatory responses provide protection but excessive inflammation may contribute to mortality, either by affecting torpor behavior or causing damage upon emergence in the spring.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26426272 PMCID: PMC4591128 DOI: 10.1371/journal.ppat.1005168
Source DB: PubMed Journal: PLoS Pathog ISSN: 1553-7366 Impact factor: 6.823
Samples used for next generation RNA sequencing.
| Sample | Location | Date Captured | Date Sampled | Sex | Mass | SMI |
| Histology | |
|---|---|---|---|---|---|---|---|---|---|
| WNS | Infl | ||||||||
| MI011 | Mine in Dickinson Co, MI | 5-Nov-2011 | 22-Mar-2012 | M | 6.70 | 6.69 | Negative | 0 | 9 |
| MN064 | Mine in Saint Louis Co, MN | 16-Nov-2011 | 22-Mar-2012 | F | 7.41 | 7.15 | Negative | 0 | 2 |
| MN075 | Mine in Saint Louis Co, MN | 16-Nov-2011 | 22-Mar-2012 | F | 7.47 | 7.68 | Negative | 0 | 50 |
| MN090 | Mine in Saint Louis Co, MN | 16-Nov-2011 | 22-Mar-2012 | M | 7.66 | 7.51 | Neg/Pos? | 0 | 13 |
| IL114 | Mine in LaSalle Co, IL | 17-Nov-2011 | 22-Mar-2012 | F | 7.13 | 7.40 | Negative | 0 | 2 |
| KY06 | Cave 1 in Breckinridge Co, KY | 12-Mar-2014 | 12-Mar-2014 | F | 6.04 | 6.17 | 120 000 | 352 | 25 |
| KY07 | Cave 1 in Breckinridge Co, KY | 12-Mar-2014 | 12-Mar-2014 | F | 6.90 | 6.89 | 13 000 | 438 | 57 |
| KY11 | Cave 1 in Breckinridge Co, KY | 12-Mar-2014 | 12-Mar-2014 | M | 5.47 | 6.12 | 169 000 | 288 | 3 |
| KY19 | Cave 2 in Breckinridge Co, KY | 12-Mar-2014 | 12-Mar-2014 | M | 6.28 | 6.93 | 64 000 | 117 | 9 |
| KY23 | Cave 2 in Breckinridge Co, KY | 12-Mar-2014 | 12-Mar-2014 | F | 6.58 | 6.89 | 21 000 | 234 | 10 |
| KY39 | Cave in Jackson Co, KY | 13-Mar-2014 | 13-Mar-2014 | M | 6.28 | 6.69 | 120 000 | 197 | 10 |
1 Scaled mass index: (mass(in g))*(38.01/(forearm length(in mm))^1.406
2 Wing swabs from MI, MN, and IL were measured in duplicate and determined to be positive for Pd if the cycle-threshold was less than 40. Samples from KY were quantified in Pd genomic equivalents relative to swabs spiked with 10 000 Pd conidia.
3 Cupping erosions characteristic of WNS per roll of wing tissue.
4 Foci of neutrophilic inflammation per roll of wing tissue.
Fig 1Hierarchical clustering of gene expression in WNS-affected and unaffected bats.
Hierarchical clustering of differentially expressed genes using Pearson correlation complete-linkage clustering. Scale shows Pearson correlation coefficient.
Fig 2Global transcriptional analysis of WNS-affected and unaffected bats by RNA-Seq.
Centered log2 fold changes are shown for the 100 most significant differentially expressed identified genes. Adjusted p values ranged from 3.3x10-5 to 2.8x10-18. The heatmap of TMM-normalized FPKM expression estimates is centered and log2 scaled from a minimum of -4.8 to a maximum of 4.8. Transcripts were identified by BLAST alignment to the SwissProt database.
Selected genes differentially expressed in WNS-affected tissues.
| Gene | Full Name | FC | pvalue | padj | EB FC | PPEE |
|---|---|---|---|---|---|---|
|
| ||||||
| IL23A | Interleukin-23 subunit alpha | 32.6 | 4.8E-09 | 2.0E-06 | 33.6 | 1.9E-08 |
| PGH2 | Prostaglandin G/H synthase 2 (Cyclooxygenase-2) | 30.5 | 1.2E-14 | 2.1E-11 | 42.3 | 3.2E-12 |
| IL6 | Interleukin-6 | 30.3 | 1.1E-10 | 9.9E-08 | 50.9 | 5.2E-09 |
| MMP25 | Matrix metalloproteinase-25 | 25.7 | 5.1E-09 | 2.0E-06 | 25.5 | 5.7E-06 |
| CSF3R | Granulocyte colony-stimulating factor receptor | 23.7 | 1.7E-09 | 9.1E-07 | 31.3 | 6.9E-08 |
| CCL20 | C-C motif chemokine 20 | 22.0 | 1.4E-07 | 3.0E-05 | 21.1 | 3.3E-06 |
| IL20 | Interleukin-20 | 20.2 | 2.9E-07 | 5.3E-05 | 21.5 | 1.5E-06 |
| CSF3 | Granulocyte colony-stimulating factor | 19.1 | 6.8E-08 | 1.8E-05 | 44.4 | 2.3E-07 |
| IL1B | Interleukin-1 beta | 17.7 | 5.6E-08 | 1.5E-05 | 13.6 | 6.6E-06 |
| IL1A | Interleukin-1 alpha | 15.4 | 4.5E-05 | 2.1E-03 | 11.4 | 3.1E-04 |
| PA21 | Phospholipase A2 | 13.8 | 3.7E-04 | 9.1E-03 | NA | NA |
| CCL2 | C-C motif chemokine 2 | 12.3 | 6.5E-06 | 5.3E-04 | 16.7 | 2.7E-05 |
| IL17C | Interleukin-17C | 10.3 | 6.5E-07 | 9.6E-05 | 12.7 | 3.0E-05 |
| IL19 | Interleukin-19 | 9.0 | 1.4E-04 | 4.7E-03 | NA | NA |
| IL24 | Interleukin-24 | 7.6 | 3.4E-08 | 1.0E-05 | 18.9 | 1.3E-05 |
| NCF2 | Neutrophil cytosol factor 2 | 5.7 | 9.9E-05 | 3.8E-03 | 5.0 | 5.6E-04 |
| PG12A | Group XIIA secretory phospholipase A2 | 2.7 | 9.4E-07 | 1.3E-04 | 3.1 | 5.7E-07 |
| S10AC | Protein S100-A12 | 2.3 | 9.0E-04 | 1.7E-02 | NA | NA |
|
| ||||||
| ABC3G | DNA dC->dU-editing enzyme APOBEC-3G | 32.4 | 3.9E-12 | 4.7E-09 | 54.2 | 4.1E-10 |
| LIRA6 | Leukocyte immunoglobulin-like receptor subfamily A member 6 | 23.1 | 1.5E-05 | 9.5E-04 | NA | NA |
| HPT | Haptoglobin | 18.9 | 3.3E-05 | 1.7E-03 | 72.2 | 3.9E-08 |
| CD3G | T-cell surface glycoprotein CD3 gamma chain | 14.8 | 6.7E-06 | 5.5E-04 | NA | NA |
| CLC4D | C-type lectin domain family 4 member D | 12.5 | 7.0E-05 | 2.9E-03 | NA | NA |
| PTPRC | Receptor-type tyrosine-protein phosphatase C | 12.3 | 1.4E-07 | 3.1E-05 | 16.0 | 1.1E-04 |
| CLC4E | C-type lectin domain family 4 member E | 12.3 | 3.6E-07 | 6.0E-05 | NA | NA |
| CLC7A | C-type lectin domain family 7 member A | 10.9 | 5.4E-07 | 8.3E-05 | NA | NA |
| CO3 | Complement C3 | 10.1 | 2.7E-03 | 3.4E-02 | 64.9 | 8.0E-08 |
| TLR9 | Toll-like receptor 9 | 8.9 | 1.4E-06 | 1.7E-04 | 6.2 | 2.5E-05 |
| S10A3 | Protein S100-A3 | 8.4 | 4.8E-04 | 1.1E-02 | NA | NA |
| CLC6A | C-type lectin domain family 6 member A | 7.0 | 1.5E-04 | 5.0E-03 | 7.0 | 3.9E-03 |
| CLC1A | C-type lectin domain family 1 member A | 6.5 | 2.4E-06 | 2.6E-04 | NA | NA |
| D103A | Beta-defensin 103A | 6.1 | 5.4E-06 | 4.7E-04 | 6.3 | 3.2E-03 |
| CLC5A | C-type lectin domain family 5 member A | 5.1 | 3.3E-04 | 8.3E-03 | NA | NA |
| BIRC3 | Baculoviral IAP repeat-containing protein 3 | 3.4 | 7.9E-05 | 3.2E-03 | 4.6 | 3.3E-04 |
| UNG | Uracil-DNA glycosylase | -3.8 | 1.0E-03 | 1.8E-02 | NA | NA |
| LEG3 | Galectin-3 | -3.4 | 5.0E-08 | 1.4E-05 | 0.28 | 1.0E-10 |
|
| ||||||
| SPRR1 | Cornifin | 184.6 | 4.1E-17 | 1.0E-13 | 66.4 | < 1E-16 |
| LCE3C | Late cornified envelope protein 3C | 17.5 | 2.1E-09 | 1.1E-06 | 15.0 | 6.2E-05 |
| FIBB | Fibrinogen beta chain | 15.9 | 1.8E-04 | 5.6E-03 | 67.2 | 5.2E-08 |
| FIBA | Fibrinogen alpha chain | 12.4 | 1.1E-03 | 1.9E-02 | 88.1 | 1.6E-08 |
| ARGI1 | Arginase-1 | 11.9 | 4.8E-04 | 1.1E-02 | NA | NA |
| FIBG | Fibrinogen gamma chain | 11.8 | 1.4E-03 | 2.2E-02 | 48.9 | 1.6E-07 |
| EPGN | Epigen | 10.3 | 2.0E-09 | 1.1E-06 | 13.1 | 7.3E-06 |
| EREG | Proepiregulin | 8.8 | 6.9E-07 | 1.0E-04 | 10.7 | 4.8E-04 |
| KLK6 | Kallikrein-6 | 8.1 | 3.4E-07 | 5.9E-05 | 9.1 | 4.2E-04 |
| K1C17 | Keratin, type I cytoskeletal 17 | 5.9 | 1.3E-05 | 8.7E-04 | 6.6 | 3.7E-03 |
| P63 | Tumor protein 63 | 3.1 | 2.0E-05 | 1.2E-03 | 16.9 | 9.8E-05 |
|
| ||||||
| PLAC8 | Placenta-specific gene 8 protein | 37.0 | 1.5E-09 | 8.4E-07 | 25.9 | 1.3E-05 |
| LIPP | Pancreatic triacylglycerol lipase | 22.3 | 1.0E-06 | 1.3E-04 | 19.4 | 2.7E-06 |
| ANGL3 | Angiopoietin-related protein 3 | 17.2 | 1.5E-04 | 4.9E-03 | NA | NA |
| APOC4 | Apolipoprotein C-IV | 16.1 | 7.9E-05 | 3.2E-03 | NA | NA |
| APOC3 | Apolipoprotein C-III | 15.8 | 1.8E-04 | 5.5E-03 | 42.5 | 8.7E-07 |
| APOC2 | Apolipoprotein C-II | 14.5 | 3.7E-04 | 9.2E-03 | 45.0 | 6.8E-07 |
| FFAR2 | Free fatty acid receptor 2 | 7.7 | 1.8E-05 | 1.1E-03 | 7.3 | 9.1E-04 |
| HCAR2 | Hydroxycarboxylic acid receptor 2 | 4.0 | 6.9E-04 | 1.4E-02 | NA | NA |
| IP6K2 | Inositol hexakisphosphate kinase 2 | -5.0 | 3.8E-06 | 3.6E-04 | 0.19 | 2.2E-03 |
| ACACA | Acetyl-CoA carboxylase 1 | -4.2 | 1.1E-03 | 1.9E-02 | 0.16 | 6.7E-03 |
|
| ||||||
| MMP3 | Stromelysin-1 | 34.0 | 3.4E-10 | 2.5E-07 | 57.7 | 6.6E-08 |
| PERT | Thyroid peroxidase | 3.7 | 2.7E-03 | 3.4E-02 | NA | NA |
| PRDX2 | Peroxiredoxin-2 | 3.6 | 1.1E-05 | 7.8E-04 | NA | NA |
| HMOX1 | Heme oxygenase 1 | 3.0 | 5.4E-04 | 1.2E-02 | 8.2 | 1.7E-03 |
1 BLAST hit with the lowest E-value in the Swissprot database. Only genes with E < 1E-05 were considered.
2 Fold change in gene expression of the WNS-affected samples compared to the unaffected samples as determined by DESeq2. Negative values indicate higher expression in the unaffected samples.
3 Probability of differential expression determined by DESeq2.
4 Adjusted probability of differential expression after Benjamini-Hochberg FDR correction.
5 Posterior probability fold change in EBSeq-estimated expression of each transcript in WNS-affected tissues over unaffected tissues. NA indicates that no isoform for that gene was differentially expressed at an FDR < 0.001
6 Posterior probability estimate by EBSeq that the isoform is differentially expressed.
Fig 3Clustering of gene expression patterns.
(A) Bootstrap analysis of regularized-log transformed counts to assign confidence levels to sample clustering. Red values are approximately unbiased p values and green values are bootstrap probabilities. Red boxes indicate clusters supported at a confidence level of 99%. (B) Principal component analysis of regularized-log transformed counts of differentially expressed genes. Black spheres represent unaffected bats and white spheres represent WNS-affected bats.
Selected over-represented gene ontology biological process categories.
| Category | GO: Biological Process Term | p | FDR | Enrich | # DE | # Cat |
|---|---|---|---|---|---|---|
| 0051246 | regulation of protein metabolic process | 4.2E-15 | 5.3E-11 | 1.46 | 344 | 1810 |
| 0006952 | defense response | 2.3E-10 | 2.2E-07 | 1.56 | 179 | 881 |
| 0051248 | negative regulation of protein metabolic process | 4.3E-10 | 2.9E-07 | 1.61 | 156 | 746 |
| 0080134 | regulation of response to stress | 9.9E-09 | 4.6E-06 | 1.46 | 194 | 1019 |
| 0044403 | symbiosis, encompassing mutualism through parasitism | 3.4E-08 | 1.2E-05 | 1.64 | 113 | 528 |
| 0006953 | acute-phase response | 3.5E-07 | 8.9E-05 | 4.11 | 15 | 28 |
| 0034097 | response to cytokine | 1.0E-06 | 2.1E-04 | 1.88 | 58 | 237 |
| 0045089 | positive regulation of innate immune response | 1.1E-06 | 2.1E-04 | 1.89 | 57 | 232 |
| 0006954 | inflammatory response | 1.1E-06 | 2.1E-04 | 1.81 | 64 | 271 |
| 0030216 | keratinocyte differentiation | 3.8E-06 | 5.4E-04 | 3.14 | 18 | 44 |
| 0070555 | response to interleukin-1 | 7.5E-06 | 9.5E-04 | 2.92 | 19 | 50 |
| 0002526 | acute inflammatory response | 8.4E-06 | 1.0E-03 | 3.11 | 17 | 42 |
| 0002755 | MyD88-dependent toll-like receptor signaling pathway | 1.7E-05 | 1.8E-03 | 2.56 | 22 | 66 |
| 0034162 | toll-like receptor 9 signaling pathway | 4.1E-05 | 3.5E-03 | 2.56 | 20 | 60 |
| 0050860 | negative regulation of T cell receptor signaling pathway | 5.7E-05 | 4.5E-03 | 4.72 | 8 | 13 |
| 2000378 | negative regulation of reactive oxygen species metabolic process | 8.7E-05 | 6.3E-03 | 3.52 | 11 | 24 |
| 0009913 | epidermal cell differentiation | 9.0E-05 | 6.5E-03 | 2.44 | 20 | 63 |
| 0030593 | neutrophil chemotaxis | 1.3E-04 | 9.1E-03 | 3.02 | 13 | 33 |
| 0002223 | stimulatory C-type lectin receptor signaling pathway | 2.3E-04 | 1.4E-02 | 2.01 | 27 | 103 |
| 0050878 | regulation of body fluid levels | 2.7E-04 | 1.6E-02 | 1.43 | 88 | 472 |
| 0051005 | negative regulation of lipoprotein lipase activity | 2.9E-04 | 1.7E-02 | 7.68 | 4 | 4 |
| 0032480 | negative regulation of type I interferon production | 3.7E-04 | 2.1E-02 | 2.77 | 13 | 36 |
1 Over-represented p value.
2 False discovery rate after Benjamini-Hochberg adjustment for multiple comparisons.
3 Enrichment of differentially expressed genes in this category.
4 Number of differentially expressed genes in this category identified by GOrilla at a p value cutoff of 0.001.
5 Number of genes in this GO category represented in the background set.
Fig 4REVIGO treemap summarizing gene ontology biological process categories over-represented in WNS-affected tissues.
GOrilla was used to identify Gene Ontology Biological Processes that were over-represented among transcripts more highly expressed in WNS-affected tissues at an FDR cutoff of 0.1 (S6 Table). Over-represented categories with p values of less than 0.001 (290 terms) were used to generate a treemap colored by functional category. The size of each rectangle is proportional to the p value for that category.
Fig 5Transcriptional analysis of Pd gene expression on bats with WNS.
Centered log2 fold changes are shown for 100 Pd genes with the greatest variance and a minimum TMM-normalized FPKM expression of 1 in all 6 samples. The heatmap is scaled from a minimum of -4.4 to a maximum of 4.4.
Fig 6Hierarchical clustering of Pd gene expression on bats with WNS.
Hierarchical clustering of differentially expressed Pd genes using Pearson correlation complete-linkage clustering. Scale shows Pearson correlation coefficient.
Expression of destructin transcripts in Pd growing on WNS-affected bats.
| Isoform | UniProt Match | Protein Name | Putative Function(s) | KY06 | KY07 | KY11 | KY19 | KY23 | KY39 |
|---|---|---|---|---|---|---|---|---|---|
| GG4320| c0_g1_i1 | ALP_ACRCH | Destructin-2 (Alkaline protease-2) | Subtilisin-family alkaline protease | 1004 | 711.7 | 1038 | 3696 | 4437 | 1157 |
| GG6167| c0_g1_i1 | ORYZ_ASPCL | Destructin-1 (Alkaline protease-1) | Subtilisin-family alkaline protease | 516.8 | 107.4 | 720.0 | 779.4 | 192.4 | 128.5 |
| GG5612| c0_g1_i1 | ORYZ_NEOFI | Destructin-3 | Subtilisin-family alkaline protease | 8.3 | 19.2 | 23.6 | 231.1 | 26.2 | 12.9 |
1 Trimmed mean of M-values- (TMM-) normalized expression determined by RSEM in fragments per kilobase of transcript per million mapped reads (FPKM).
Possible virulence genes expressed in Pd growing on WNS-affected bats.
|
| UniProt Match | Protein Name | Putative Function | TMM-normalized expression by RSEM (FPKM) | |||||
|---|---|---|---|---|---|---|---|---|---|
| KY06 | KY07 | KY11 | KY19 | KY23 | KY39 | ||||
| GG1839|c0_g1 | MSBP2_ARATH | Membrane steroid-binding protein 2 | Antimicrobial peptide response | 63.6 | 146.4 | 30.1 | 24.8 | 65.3 | 48.2 |
| GG5000|c0_g1 | DUR3_YEAST | Urea active transporter | Antimicrobial peptide susceptibility | 65.7 | 79.5 | 107.0 | 51.6 | 19.8 | 14.6 |
| GG5000|c1_g1 | DUR31_SCHPO | Probable urea active transporter 1 | Antimicrobial peptide susceptibility | 0 | 79.5 | 0 | 81.1 | 102.1 | 0 |
| GG680|c0_g1 | GMDG_00178 | Uncharacterized protein | Drug resistance transporter | 0 | 29.7 | 24.4 | 141.0 | 175.2 | 39.8 |
| GG2580|c0_g1 | SOL5_ALTSO | Bifunctional solanapyrone synthase | Phytotoxin synthesis, Pathogenesis | 101.4 | 0 | 0 | 157.3 | 99.2 | 0 |
| GG6092|c0_g1 | SOL5_ALTSO | Bifunctional solanapyrone synthase | Phytotoxin synthesis, Pathogenesis | 66.4 | 35.8 | 113.6 | 714.7 | 1116 | 352.5 |
| GG3668|c0_g1 | TOXA_COCCA | Putative HC-toxin efflux carrier TOXA | Toxin transporter | 20.4 | 0 | 77.5 | 143.8 | 85.0 | 62.7 |
| GG3668|c1_g1 | TOXA_COCCA | Putative HC-toxin efflux carrier TOXA | Toxin transporter | 78.6 | 0 | 74.4 | 122.5 | 40.1 | 0 |
| GG432|c0_g1 | TOXA_COCCA | Putative HC-toxin efflux carrier TOXA | Toxin transporter | 114.0 | 35.1 | 54.2 | 89.5 | 131.9 | 53.1 |
| GG432|c1_g1 | TOXA_COCCA | Putative HC-toxin efflux carrier TOXA | Toxin transporter | 42.5 | 49.0 | 20.2 | 66.5 | 132.5 | 0 |
| GG680|c1_g1 | TOXA_COCCA | Putative HC-toxin efflux carrier TOXA | Toxin transporter | 27.1 | 20.9 | 12.9 | 148.7 | 198.9 | 0 |
| GG1568|c0_g1 | CHI1_COCP7 | Endochitinase 1 | Fungal cell wall | 305.2 | 26.9 | 348.1 | 581.9 | 46.0 | 27.2 |
| GG2156|c0_g1 | YCZ2_SCHPO | Putative mannan endo-1,6-alpha-mannosidase | Fungal cell wall | 32.5 | 6.3 | 7.7 | 57.4 | 214.3 | 113.9 |
| GG1843|c0_g1 | ENG1_SCHPO | Endo-1,3(4)-beta-glucanase 1 | Fungal cell wall | 77.7 | 0 | 62.1 | 196.4 | 8.6 | 26.0 |
| GG2744|c0_g1 | BGLE_NEOFI | Probable beta-glucosidase E | Fungal cell wall | 115.2 | 355.1 | 84.6 | 65.8 | 77.6 | 8.2 |
| GG2744|c1_g1 | BGLE_NEOFI | Probable beta-glucosidase E | Fungal cell wall | 0 | 238.0 | 0 | 0 | 124.6 | 0 |
| GG4455|c0_g1 | AVR4_PASFU | Race-specific elicitor A4 | Fungal cell wall, Pathogenesis | 106.3 | 5.1 | 158.0 | 866.6 | 309.2 | 166.0 |
| GG2938|c0_g1 | BGBP_PENMO | Beta-1,3-glucan-binding protein | Innate immune activation | 121.2 | 85.2 | 150.4 | 34.5 | 68.4 | 104.5 |
| GG2938|c0_g2 | BGBP_PENMO | Beta-1,3-glucan-binding protein | Innate immune activation | 840.1 | 332.2 | 768.8 | 783.6 | 476.6 | 339.3 |
| GG6498|c0_g1 | SR1A_PHYPO | Spherulin-1A | Manganese binding | 1067 | 629.2 | 1202 | 217.1 | 373.4 | 6328 |
| GG3236|c0_g1 | SBNA_RALME | Pd uncharacterized protein L8FZ85 | Siderophore biosynthesis | 68.3 | 205.4 | 60.5 | 48.3 | 192.0 | 0 |
| GG4315|c0_g2 | FRE3_YEAST | Ferric reductase transmembrane component 3 | Siderophore transport, Iron binding | 157.9 | 86.4 | 135.7 | 76.1 | 86.4 | 95.6 |
| GG5300|c0_g1 | FRE3_YEAST | Ferric reductase transmembrane component 3 | Siderophore transport, Iron binding | 2422 | 1441 | 1623 | 510.9 | 400.3 | 197.0 |
| GG6235|c0_g1 | SIT1_YEAST | Siderophore iron transporter 1 | Siderophore transporter | 0 | 0 | 0 | 23.1 | 135.3 | 0 |
| GG6235|c0_g2 | SIT1_YEAST | Siderophore iron transporter 2 | Siderophore transporter | 115.7 | 133.8 | 170.1 | 191.2 | 74.4 | 107.0 |
| GG2118|c0_g2 | ZRT1_YEAST | Zinc-regulated transporter 1 | Zinc transporter | 1873 | 1637 | 1447 | 924.5 | 1211 | 501.3 |
| GG5016|c0_g2 | ZRT1_YEAST | Zinc-regulated transporter 2 | Zinc transporter | 457.4 | 310.7 | 449.3 | 66.9 | 137.0 | 564.1 |
| GG3064|c0_g1 | MIRB_EMENI | Siderophore iron transporter mirB | Response to iron ion starvation | 547.5 | 169.3 | 220.7 | 136.1 | 425.8 | 259.6 |
| GG861|c0_g1 | MIRB_EMENI | Siderophore iron transporter mirB | Response to iron ion starvation | 656.0 | 410.1 | 712.3 | 913.4 | 1324 | 541.4 |
| GG4694|c1_g1 | LAC2_PODAS | Laccase-2 | Melanin biosynthesis | 64.2 | 19.8 | 329.4 | 553.8 | 69.1 | 179.0 |
| GG6611|c0_g1 | UREA_ASPFU | Urease | Nitrogen metabolism | 49.8 | 0 | 0 | 38.8 | 151.1 | 222.7 |
| GG6611|c1_g1 | UREA_ASPFU | Urease | Nitrogen metabolism | 0 | 28.2 | 34.8 | 28.6 | 112.6 | 0 |
| GG6611|c3_g1 | UREA_ASPFU | Urease | Nitrogen metabolism | 0 | 54.8 | 0 | 55.7 | 142.6 | 0 |
| GG6612|c0_g1 | UREA_ASPFU | Urease | Nitrogen metabolism | 0 | 0 | 0 | 499.6 | 0 | 0 |
| GG3518|c0_g1 | ALL2_ASPFU | Major allergen Asp f 2 | Metallopeptidase, Fungal allergen | 2789 | 4105 | 1021 | 3510 | 5373 | 449.6 |
| GG2311|c0_g1 | PRTA_ASPNG | Aspergillopepsin-2 | Aspartic endopeptidase | 59.3 | 79.9 | 84.5 | 709.2 | 1149 | 68.8 |
| GG2082|c0_g1 | PEPA_ASPOR | Aspartic protease pep1 | Secreted aspartic endopeptidase | 64.5 | 31.0 | 45.9 | 95.5 | 370.1 | 0 |
| GG2082|c0_g2 | PEPA_ASPOR | Aspartic protease pep1 | Secreted aspartic endopeptidase | 0.1 | 0.1 | 0.1 | 189.7 | 5.1 | 0 |
| GG4492|c0_g1 | CARP_CRYPA | Endothiapepsin | Secreted aspartic endopeptidase | 648.7 | 460.5 | 311.8 | 406.5 | 423.6 | 216.0 |
| GG448|c0_g1 | LAP1_SCLS1 | Leucine aminopeptidase 1 | Secreted leucyl endopeptidase | 100.7 | 84.0 | 95.7 | 283.3 | 265.6 | 183.0 |
| GG788|c0_g1 | SPM1_MAGO7 | Subtilisin-like proteinase Spm1 | Secreted serine endopeptidase | 956.8 | 952.7 | 525.5 | 1260 | 1176 | 919.4 |
| GG2765|c0_g1 | PEPS_ASPPH | Carboxypeptidase cpdS | Serine carboxypeptidase | 83.2 | 114.5 | 146.9 | 775.2 | 981.3 | 408.6 |
| GG3562|c1_g1 | SED4_ARTOC | Tripeptidyl-peptidase SED4 | Serine endopeptidase, Pathogenesis | 715.7 | 366.5 | 690.3 | 1703 | 2009 | 191.9 |
| GG2259|c0_g1 | SOD6_CANAL | Cell surface superoxide dismutase [Cu-Zn] 6 | Superoxide metabolism, Pathogenesis | 43.5 | 44.6 | 13.8 | 556.7 | 880.6 | 179.3 |
| GG4408|c0_g1 | CCPR2_ASPFU | Putative heme-binding peroxidase | Oxidative stress response, Iron binding | 1044 | 842.8 | 477.1 | 63.0 | 42.3 | 421.4 |
| GG6788|c0_g1 | HOG1_CRYPA | Mitogen-activated protein kinase HOG1 | Virulence and conidia formation | 735.1 | 816.2 | 959.1 | 325.7 | 373.5 | 772.8 |